Triamhexal 40mg 5 Amp. x 1 ml

Nr.
100116
Brand:
Hexal
Batch:
KB7432
Expiry date:
30-Nov-2022
For alleviating the joint pain, swelling and stiffness
More info


Indications
Intra-articular use: for alleviating the joint pain, swelling and stiffness associated with rheumatoid arthritis and osteoarthrosis, with an inflammatory component; also for bursitis, epicondylitis, and tenosynovitis.

Intramuscular use: Where sustained systemic corticosteroid treatment is required: Allergic states, e.g. bronchial asthma, seasonal or perennial allergic rhinitis. In seasonal allergies, patients who do not respond to conventional therapy may achieve a remission of symptoms over the entire period with a single intramuscular injection (see Dosage); Endocrine disorders, e.g. primary or secondary adrenocortical insufficiency. Collagen disorders, e.g. during an exacerbation of maintenance therapy of selected cases of SLE or acute rheumatic carditis; Dermatological diseases, e.g. pemphigus, severe dermatitis and Stevens Johnson Syndrome; Rheumatic, Gastrointestinal or Respiratory disorders - as an adjunctive, short-term therapy; Haematological disorders, e.g. acquired (autoimmune) haemolytic anaemia; Neoplastic diseases, e.g. palliative management of leukaemia and lymphomas; Renal disease, such as acute interstitial nephritis, minimal change nephrotic syndrome or lupus nephritis.

Dosage and administration
Intra-Articular Injection: For intra-articular administration or injection into tendon sheaths and bursae, 2.5 to 15mg, subcutaneous or direct  Injection  up to 40mg (1.0ml) for larger joints, depending on the specific disease entity being treated. Single injections into several sites for multiple joint involvement, up to a total of 80mg, have been given without undue reactions.

Adults and Children over 12 Years: The suggested initial dose is 40mg (1.0ml) injected deeply into the upper, outer quadrant of the gluteal muscle. Subsequent dosage depends on the patient's response and period of relief. Patients with hay fever or pollen asthma who do not respond to conventional therapy may obtain a remission of symptoms lasting throughout the pollen season after a single dose of 40-100mg given when allergic symptoms appear.

Children from 6-12 Years of Age: 2.5 to 15 ml which might be repeated if needed.

More Information
Nr.100116
Registration numberHuman
BrandHexal
ChilledNo
Active IngredientTriamcinolone
Withdrawal periodtriamcinolonacetonide
BatchKB7432
Expiry dateNov 30, 2022
Units per outer box5
IngredientsTriamcinolone
© 2020 Grovet B.V. All rights reserved.